Foundation laid for new Q fever vaccine
Three years of research at, among others, Innatoss Laboratories in Oss laid the foundation for a new Q fever vaccine....
Read more
Scientist Silvie Meeuwissen: “My interest is mainly in the practical applications of chemistry”
Silvie Meeuwissen (1985) has been working as a Principal Scientist at ChemConnection B.V. since 2014. The company that was founded in 2012 by two former Organon employees is one of the few companies in Europe that focuses on commercialization of medical applications for nanotechnology.
Read more
New at Pivot Park – Agidens
Agidens is a Belgian company and helps customers in improving processes by means of specialty advice, engineering, automation solutions and...
Read more
Synaffix ADC Technology enters the clinic
ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-601 in Advanced Solid Tumors Pyrrolobenzodiazepine-based antibody drug...
Read more
A cup of coffee with… Cindy Oppers
“PPSC crossed my path and I didn’t want to let this opportunity pass me by.” Recently Cindy Oppers started as...
Read more
Synaffix Announces License Agreement with Mersana Therapeutics
Synaffix announced it has entered into a license agreement with Mersana Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on discovering...
Read more
NanoSERVE expands its presence at Pivot Park with the spinout company SUBLIN BV.
NanoSERVE BV announces the launch of its spinout company SUBLIN BV, which aims to provide diabetic patients a disruptive alternative...
Read more
Chemist Freek van Cauter: ‘We make molecules here’
At NTRC, chemists and biologists work closely together to develop new drugs, particularly against cancer and Parkinson's disease. Chemist Freek van Cauter gives us a look behind the scenes.
Read more